High tuberculosis incidence among people living with diabetes in Indonesia
Susan McAllister, Raspati Cundarani Koesoemadinata, Prayudi Santoso, Nanny Natalia Mulyani Soetedjo, Abdul Kamil, Hikmat Permana, Rovina Ruslami, Julia Critchley, et al. (11 authors)
Transactions of the Royal Society of Tropical Medicine and Hygiene · 2019-09
Abstract
BACKGROUND: Data regarding the incidence of tuberculosis (TB) among people living with diabetes (PLWD) in TB-endemic settings are scarce. We examined TB incidence among PLWD in Indonesia who had previously been screened for latent TB infection (LTBI) and TB disease. METHODS: PLWD (≥18 y of age) in an urban setting were examined a mean 3.4 y after they had been screened for active TB and LTBI. Data on subsequent TB diagnosis were collected by interview and with chest X-ray, sputum smear and Mycobacterium tuberculosis culture. TB incidence rates were stratified for baseline LTBI status, as determined by the QuantiFERON interferon-gamma release assay (IGRA). RESULTS: Of 590 PLWD, 101 had died and 163 could not be contacted or refused. Among the 326 who were re-examined, 6 (1.8%; 95% confidence interval [CI] 0.7 to 4.0) reported being diagnosed already and a further 5 were diagnosed with active TB (1.5%; 95% CI 0.50 to 3.5). The TB incidence rate was 9.85 (95% CI 4.03 to 15.68) per 1000 person-years. TB incidence was higher among PLWD with baseline LTBI (17.13; 95% CI 5.25 to 29.00/1000 person-years) compared with those without LTBI (4.79; 95% CI -0.63 to 10.21), with an incidence rate ratio of 3.57 (95% CI 0.86 to 20.92; p=0.054). CONCLUSIONS: PLWD with LTBI in Indonesia and similar settings are likely to benefit from TB preventive therapy.
MeSH terms
- Medicine
- Incidence (geometry)
- Tuberculosis
- Interferon gamma release assay
- QuantiFERON
- Latent tuberculosis
- Sputum
- Mycobacterium tuberculosis
- Confidence interval
- Internal medicine
- Diabetes mellitus